DavidCSmithMD

Oncology • Ann Arbor, MI

Genitourinary Oncology, Hematologic Oncology

Professor of Medicine and Urology University of Michigan

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Summary

Dr. David Smith is an oncologist in Ann Arbor, MI and is affiliated with the University of Michigan Medical Center and Michigan Medicine. He received his medical degree from University of Washington School of Medicine and has been in practice 32 years. He specializes in genitourinary oncology and is experienced in clinical trials, prostate and bladder cancer, and testicular neoplasms.

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 1989 - 1992
University of WashingtonResidency, Internal Medicine, 1985 - 1988
University of Washington School of MedicineClass of 1985

Certifications & Licensure

MI State Medical License 1995 - 2027
PA State Medical License 1992 - 1996
NC State Medical License 1990 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Circulating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies.
Daniel Wenzel, Andrew M Schuler, David C Smith, Joseph R Evans, Kelly L Harms
JAAD Case Reports. 2024-10-01
Incidental testicular germ cell tumor in a transgender woman: A case report.
R Evey Aslanian, Cole Roblee, David C Smith, Rohit Mehra, William M Kuzon Jr
Urology Case Reports. 2024-09-01
8 citations
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.
Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel
Journal for Immunotherapy of Cancer. 2023-06-01

Journal Articles

Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
David Smith, Sarah Yentz, Biodrugs

Press Mentions

David Smith Retires with a Legacy of Compassionate Patient CareOctober 16th, 2024

Professional Memberships